Skip to main content
Equibles

MetLife Investment Management, LLC

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1529735 Whippany, NJ
Back to RXRX Full portfolio

Position in RXRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,103,213
+$331,072 QoQ
Shares Held
300,603
+19.5% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#68
of 343 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RXRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $433,929,439 across 249 Biotechnology names. RXRX ranks #76 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HALO
Halozyme Therapeutics, Inc.
 402,605 $31,511,893
2 PRAX
Praxis Precision Medicines, Inc.
 90,543 $30,312,890
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 58,072 $28,846,104
4 FTRE
Fortrea Holdings Inc.
 1,362,169 $23,701,740
5 AXSM
Axsome Therapeutics, Inc.
 89,662 $21,946,567
6 IMNM
Immunome Inc.
 859,076 $18,203,820
7 REGN
Regeneron Pharmaceuticals, Inc.
 22,880 $14,266,595
8 CYTK
Cytokinetics Inc
 140,046 $11,930,518

All Filings in RXRX

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,103,213 300,603
2026-03-31 $772,141 251,512
2025-12-31 $858,086 209,801
2025-09-30 $1,050,371 215,240
2025-06-30 $1,032,644 204,080
2025-03-31 $782,957 148,007
2024-12-31 $1,012,702 149,808
2024-09-30 $899,805 136,541
2024-06-30 $901,020 120,136
2024-03-31 $719,445 72,161
2023-12-31 $711,507 72,161
2023-09-30 $552,031 72,161
2023-06-30 $539,042 72,161
2023-03-31 $481,313 72,161
2022-12-31 $556,361 72,161
2022-09-30 $767,793 72,161
2022-06-30 $587,390 72,161
2022-03-31 $458,490 64,035
2021-12-31 $705,790 41,202
2021-09-30 $247,380 10,751
2021-06-30 $317,842 8,708